Sfoglia per AUTORE
BIRONZO P
Collezione AOU San Luigi di Orbassano

  

Items : 85

Immunotherapy in advanced non-small cell lung cancer: What to do for the 'Invisible' patients after IPSOS trial results? in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2025 Mar 7;202:108482. doi: 10.1016/j.lungcan.2025.108482.
2025
AOU San Luigi di Orbassano

Gridelli C; Attili I; Bennati C; Bironzo P; Bria E; Cortinovis DL; Soto Parra H; de Marinis F;

The evolving landscape of stage III unresectable non-small cell lung cancer "between lights and shadows". in Cancer treatment reviews / Cancer Treat Rev. 2025 Mar 11;135:102918. doi: 10.1016/j.ctrv.2025.102918.
2025
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Ricardi U; Levis M; Capelletto E; Bironzo P; Merlini A; Reale ML; Ungaro A; Cani M; Garbo E; Napoli VM; Mogavero A; Saba G; Crespi V; Delcuratolo MD; Novello S; Passiglia F;

Role of osimertinib plus brain radiotherapy versus osimertinib single therapy in EGFR-mutated non-small-cell lung cancer with brain metastases: A meta-analysis and systematic review. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2025 Jan;205:104540. doi: 10.1016/j.critrevonc.2024.104540. Epub 2024 Oct 30
2025
AOU San Luigi di Orbassano

Nepote A; Poletto S; Bertaglia V; Carnio S; Piumatti C; Lanzetta C; Cantale O; Saba G; Bironzo P; Novello S; Tralongo AC;

2025
AOU San Luigi di Orbassano
AOU Novara

Wakelee H; Garassino M; Peters S; Takada K; Naqash AR; Torri V; Hejleh TA; Ferrara R; Aerts JGJV; Aboubakar Nana F; Dingemans AM; Biello F; Rogado J; Moliner L; Beninato T; Lo Russo G; Servetto A; Mezquita L; Gorría T; Minuti G; Bennati C; Tonini G; Cortinovis DL; Agustoni F; Majem M; Baena J; Macerelli M; Monnet I; O'Reilly D; et alii...

From Cancer to Immune Organoids: Innovative Preclinical Models to Dissect the Crosstalk between Cancer Cells and the Tumor Microenvironment. in International journal of molecular sciences / Int J Mol Sci. 2024 Oct 9;25(19):10823. doi: 10.3390/ijms251910823.
2024
AOU San Luigi di Orbassano

Picca F; Giannotta C; Tao J; Giordanengo L; Munir HMW; Botta V; Merlini A; Mogavero A; Garbo E; Poletto S; Bironzo P; Doronzo G; Novello S; Taulli R; Bersani F;

Niraparib plus Dostarlimab in Pleural Mesothelioma or Non-Small Cell Lung Cancer Harboring HRR Mutations: Interim Results of the UNITO-001 Phase II Prospective Trial. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2024 Mar 1;30(5):959-964. doi: 10.1158/1078-0432.CCR-23-2431.
2024
AOU San Luigi di Orbassano

Passiglia F; Righi L; Bironzo P; Listì A; Farinea G; Capelletto E; Novello S; Merlini A; Scagliotti GV;

Mismatch Repair Deficiency in Lung Tumors: Adding a New Layer of Complexity on Pie Slices. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2024 Mar;19(3):363-365. doi: 10.1016/j.jtho.2023.11.023.
2024
AOU San Luigi di Orbassano

Cani M; Novello S; Bironzo P;

CT-Guided Core Needle Biopsy of Pulmonary Lesions Associated With Cystic Airspaces: A Case-Control Study. in AJR. American journal of roentgenology / AJR Am J Roentgenol. 2024 Jul;223(1):e2431042. doi: 10.2214/AJR.24.31042. Epub 2024 May 8.
2024
ASL Cuneo 2
AOU San Luigi di Orbassano

Righi L; Novello S; Sverzellati N; Bironzo P; Levra S; Napoli F; Filipello F; Senkeev R; Barba M; Culasso NC; Caroli A; Capelli S; Balbi M; Veltri A;

Epigenetic determinants in soft tissue sarcomas: molecular mechanisms and therapeutic targets. in Expert opinion on therapeutic targets / Expert Opin Ther Targets. 2024 Jan-Feb;28(1-2):17-28. doi: 10.1080/14728222.2024.2306344. Epub 2024
2024
AOU San Luigi di Orbassano

Merlini A; Rabino M; Brusco S; Pavese V; Masci D; Sangiolo D; Bironzo P; Scagliotti GV; Novello S; D'Ambrosio L;

Meta-Analysis on the Combination of Chemotherapy With Programmed Death-Ligand 1 and Programmed Cell Death Protein 1 Blockade as First-Line Treatment for Unresectable Pleural Mesothelioma. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2024 Jan;19(1):166-172. doi: 10.1016/j.jtho.2023.08.004. Epub 2023 Aug 9.
2024
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Planchard D; Besse B; Novello S; Barlesi F; Le Péchoux C; Facchinetti F; Aldea M; Genova C; Bironzo P; Di Maio M; Remon J; Tagliamento M; Tagliamento M; Di Maio M; Remon J; Bironzo P; Genova C; Facchinetti F; Aldea M; Le Péchoux C; Novello S; Barlesi F; Besse B; Planchard D;

Clinical evidence and adverse event management update of patients with RET- rearranged advanced non-small-cell lung cancer (NSCLC) treated with pralsetinib. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2024 Feb;194:104243. doi: 10.1016/j.critrevonc.2023.104243. Epub 2023 Dec 20
2024
AOU San Luigi di Orbassano

Russo GL; Bironzo P; Bennati C; Bonanno L; Catino A; Metro G; Petrini I; Russano M; Passaro A; Russo GL; Bironzo P; Bennati C; Bonanno L; Catino A; Metro G; Petrini I; Russano M; Passaro A;

Actionable NSCLC Mutation Identification by Comprehensive Genomic Profiling for Clinical Trial Enrollment: The European Program for the Routine Testing of Patients With Advanced Lung Cancer (EPROPA). in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2024 Dec 16:S1556-0864(24)02529-2. doi: 10.1016/j.jtho.2024.12.010.
2024
ASL Cuneo 2
ASL Asti
AOU San Luigi di Orbassano

Novello S; Scagliotti G; Righi L; Vallone S; Malapelle U; Volante M; Giannarelli D; Mohorcic K; Meoni G; Scotti V; Linardou H; Bettini AC; Ramizi KM; Secen N; Comanescu A; Felip E; Paz-Ares L; Pignataro D; Araujo A; Barbieri V; Mazilu L; Buffoni L; Taveggia PA; Simionato F; Roca E; Sini C; Tabbò F; Reale ML; Zambelli V; et alii...

Letter Re: Indirect comparison of capmatinib treatment from GEOMETRY mono-1 trial to SOC in German patients with locally advanced or metastatic NSCLC harboring METex14 skipping mutations. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2024 Dec;213:115085. doi: 10.1016/j.ejca.2024.115085. Epub 2024 Oct 28.
2024
AOU San Luigi di Orbassano

Sini C; Di Federico A; Bironzo P; De Giglio A; Gelsomino F;

A case series of non-small cell lung cancer patients with EGFR or HER2 exon 20 insertion in Li Fraumeni syndrome. in Tumori / Tumori. 2024 Dec;110(6):NP5-NP10. doi: 10.1177/03008916241255485. Epub 2024 May 23.
2024
AOU San Luigi di Orbassano

Cognigni V; Capelletto E; Bordi P; Pavese V; Carfì FM; Gelsomino F; De Giglio A; Chiari R; Minari R; Ambrosini E; Percesepe A; Giachino D; Bironzo P; Tiseo M;

BAP1 Loss, Nuclear Grading, and Nonepithelioid Features in the Diagnosis of Mesothelioma in Italy: Nevermore without the Pathology Report. in Journal of personalized medicine / J Pers Med. 2024 Apr 8;14(4):394. doi: 10.3390/jpm14040394.
2024
AOU Alessandria
AOU San Luigi di Orbassano

Galetta D; Ceresoli GL; Davolio MC; Dianzani I; Abate-Daga L; Sculco M; Malapelle U; Pisapia P; Grosso F; Spagnolo P; Tiseo M; Barbisan F; Righi L; Rossi G; Pasello G; Novello S; Bironzo P;

2023
AOU San Luigi di Orbassano

Bertero L; Cassoni P; Ricardi U; Ricci AA; Mangherini L; Bironzo P; Mantovani C; De Giorgi G; Gastino A; Levis M;

The Role of Germline Mutations in Thoracic Malignancies: Between Myth and Reality. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2023 Sep;18(9):1146-1164. doi: 10.1016/j.jtho.2023.05.028. Epub 2023 Jun 16.
2023
AOU San Luigi di Orbassano

Farinea G; Crespi V; Listì A; Righi L; Bironzo P; Merlini A; Malapelle U; Novello S; Scagliotti GV; Passiglia F;

Deciphering Lung Adenocarcinoma Heterogeneity: An Overview of Pathological and Clinical Features of Rare Subtypes. in Life (Basel, Switzerland) / Life (Basel). 2023 May 31;13(6):1291. doi: 10.3390/life13061291.
2023
AOU San Luigi di Orbassano

Mogavero A; Bironzo P; Righi L; Merlini A; Benso F; Novello S; Passiglia F;

Exploring circular MET RNA as a potential biomarker in tumors exhibiting high MET activity. in Journal of experimental & clinical cancer research : CR / J Exp Clin Cancer Res. 2023 May 12;42(1):120. doi: 10.1186/s13046-023-02690-5.
2023
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Bardelli A; Di Nicolantonio F; Pietrantonio F; Poli V; Monteleone E; Bironzo P; Tabbò F; Benso F; Zambelli V; Listì A; Volante M; Castella B; Rospo G; Negrino C; Oddo D; Russo M; Napoli F; Righi L; Morena D; Picca F; Bersani F; Ponzetto C; Novello S; Scagliotti GV; Taulli R;

Consensus clustering methodology to improve molecular stratification of non-small cell lung cancer. in Scientific reports / Sci Rep. 2023 May 12;13(1):7759. doi: 10.1038/s41598-023-33954-x.
2023
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Sabbatini G; Righi L; Primo L; Pittaro A; Parab S; Papotti M; Novello S; Monica V; Guerrera F; Gandolfi L; Falco P; Errico L; Doronzo G; Corti G; Corà D; Colombi D; Cipollini F; Bianco S; Bironzo P; Manganaro L; Sandri A; Vattakunnel S; Bussolino F; Scagliotti GV;

Rare thoracic cancers: a comprehensive overview of diagnosis and management of small cell lung cancer, malignant pleural mesothelioma and thymic epithelial tumours. in European respiratory review : an official journal of the European Respiratory Society / Eur Respir Rev. 2023 Feb 7;32(167):220174. doi: 10.1183/16000617.0174-2022. Print 2023 Mar 31.
2023
AOU San Luigi di Orbassano

Dumoulin DW; Bironzo P; Passiglia F; Scagliotti GV; Aerts JGJV;

Real-world retrospective study of KRAS mutations in advanced non-small cell lung cancer in the era of immunotherapy. in Cancer / Cancer. 2023 Jun 1;129(11):1662-1671. doi: 10.1002/cncr.34731. Epub 2023 Mar 11.
2023
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Novello S; Di Maio M; Righi L; Passiglia F; Listì A; Napoli VM; Jacobs F; Cani M; Bironzo P; Scagliotti GV;

2023
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Passiglia F; Novello S; Gianetta M; Di Maio M; D'Amiano C; Capelletto E; Bianco V; Bertaglia V; Napoli VM; Leone G; Cecchi C; Audisio A; Turco F; Delcuratolo MD; Cetoretta V; Pisano C; Parlagreco E; Garbo E; Ferrari G; Del Rio B; Cani M; Persano I; Scagliotti GV; Bironzo P;

Immune Checkpoint Inhibitors in Patients With Cancer and Infection by Hepatitis B or C Virus: A Perspective Through the Results of a European Survey. in JTO clinical and research reports / JTO Clin Res Rep. 2022 Dec 15;4(1):100446. doi: 10.1016/j.jtocrr.2022.100446. eCollection 2023 Jan.
2023
AOU San Luigi di Orbassano

Novello S; Besse B; Bironzo P; De Maria A; Giaj Levra M; Remon J; Tagliamento M; Mezquita L;

An Italian Multicenter Perspective Harmonization Trial for the Assessment of MET Exon 14 Skipping Mutations in Standard Reference Samples. in Diagnostics (Basel, Switzerland) / Diagnostics (Basel). 2023 Feb 8;13(4):629. doi: 10.3390/diagnostics13040629.
2023
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Seminati D; Lacalamita R; Tommasi S; Galafate D; Scarpino S; Salemi D; Santoro A; Farioli RM; Movilia A; Giusti A; Sibona F; Francia di Celle P; Bresciani MA; Ferrero G; Buglioni S; Bartoccini F; Bessi S; Aquino G; Gragnano G; Pisapia P; Russo G; Pepe F; Bironzo P; Sajjadi E; Novello S; Pagni F; Troncone G; Malapelle U;

Novel Lymphocyte-Independent Antitumor Activity by PD-1 Blocking Antibody against PD-1+ Chemoresistant Lung Cancer Cells. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2023 Feb 1;29(3):621-634. doi: 10.1158/1078-0432.CCR-22-0761.
2023
AOU San Luigi di Orbassano

Rotolo R; Leuci V; Donini C; Galvagno F; Massa A; De Santis MC; Peirone S; Medico G; Sanlorenzo M; Vujic I; Gammaitoni L; Basiricò M; Righi L; Riganti C; Salaroglio IC; Napoli F; Tabbò F; Mariniello A; Vigna E; Modica C; D'Ambrosio L; Grignani G; Taulli R; Hirsch E; Cereda M; Aglietta M; Scagliotti GV; Novello S; Bironzo P; et alii...

Tumor plasticity and therapeutic resistance in oncogene-addicted non-small cell lung cancer: from preclinical observations to clinical implications. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2023 Apr;184:103966. doi: 10.1016/j.critrevonc.2023.103966. Epub 2023 Mar 15
2023
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Scagliotti GV; Taulli R; Yoshizumi T; Novello S; Seto T; Haratake N; Takenaka T; Tabbò F; Picca F; Bersani F; Bironzo P; Toyokawa G;

Clinical-Molecular Prospective Cohort Study in Non-Small Cell Lung Cancer (PROMOLE study): A Comprehensive Approach to Identify New Predictive Markers of Pharmacological Response. in Clinical lung cancer / Clin Lung Cancer. 2022 Sep;23(6):e347-e352. doi: 10.1016/j.cllc.2022.05.007. Epub 2022 May 11.
2022
AOU San Luigi di Orbassano

Bironzo P; Primo L; Novello S; Righi L; Candeloro S; Manganaro L; Bussolino F; Pirri F; Scagliotti GV;

2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Sangiolo D; Righi L; Passiglia F; Di Maio M; Paratore C; Bungaro M; De Filippis M; Consito L; Mecca C; Bertaglia V; Carnio S; Capelletto E; Listì A; Reale ML; Rezmives NA; Tesauro M; Indellicati D; Tabbò F; Mariniello A; Novello S; Geuna M; Bironzo P;

Results of screening in early and advanced thoracic malignancies in the EORTC pan-European SPECTAlung platform. in Scientific reports / Sci Rep. 2022 May 18;12(1):8342. doi: 10.1038/s41598-022-12056-0.
2022
AOU San Luigi di Orbassano

Morfouace M; Novello S; Stevovic A; Dooms C; Janži? U; Berghmans T; Dziadziuszko R; Gorlia T; Felip E; Paz-Ares L; Mazieres J; O'Brien M; Bironzo P; Vansteenkiste J; Lacroix L; Dingemans AC; Golfinopoulos V; Besse B;

Optimizing the clinical management of EGFR-mutant advanced non-small cell lung cancer: a literature review. in Translational lung cancer research / Transl Lung Cancer Res. 2022 May;11(5):935-949. doi: 10.21037/tlcr-22-1.
2022
AOU San Luigi di Orbassano

Passiglia F; Bironzo P; Bertaglia V; Listì A; Garbo E; Scagliotti GV;

2022
AOU San Luigi di Orbassano

Wen S; Du X; Chen Y; Xia J; Wang R; Zhu M; Peng W; Spitaleri G; Hofman P; Bironzo P; Wang X; Shen B;

Nutritional support in lung cancer: Time to combine immunonutrition with immunotherapy? in Nutrition (Burbank, Los Angeles County, Calif.) / Nutrition. 2022 Jun;98:111637. doi: 10.1016/j.nut.2022.111637. Epub 2022 Mar 3.
2022
AOU San Luigi di Orbassano

Pilotto S; Agustoni F; Morelli AM; Lobascio F; Cereda E; Bironzo P; Trestini I; Milella M; Novello S; Pedrazzoli P; Caccialanza R;

Exercise in lung Cancer, the healthcare providers opinion (E.C.H.O.): Results of the EORTC lung cancer Group (LCG) survey. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2022 Jul;169:94-101. doi: 10.1016/j.lungcan.2022.05.009. Epub 2022 May 19.
2022
AOU San Luigi di Orbassano

Pilotto S; Avancini A; Menis J; Sperduti I; Giaj Levra M; Berghmans T; Bironzo P; Brandão M; De Ruysscher D; Edwards J; Faivre-Finn C; Girard N; Greillier L; Hendriks L; Lantuejoul S; Mauer M; Novello S; O'Brien M; Reck M; Reguart N; Remon J; von der Thüsen J; Dingemans AC; Besse B; Milella M;

Emergency room comprehensive assessment of demographic, radiological, laboratory and clinical data of patients with COVID-19: determination of its prognostic value for in-hospital mortality. in Internal and emergency medicine / Intern Emerg Med. 2022 Jan;17(1):205-214. doi: 10.1007/s11739-021-02669-0. Epub 2021 Mar 8.
2022
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Faletti R; Fonio P; Limerutti G; Veltri A; Riccardini F; Caironi P; Cardinale L; Cavallo R; Brazzi L; Boccuzzi A; Bironzo P; Bergamasco L; Varello S; Piatti C; Ruggirello I; Santonocito A; Biondo A; Geninatti C; Calandri M; Gatti M;

SKP2 drives the sensitivity to neddylation inhibitors and cisplatin in malignant pleural mesothelioma. in Journal of experimental & clinical cancer research : CR / J Exp Clin Cancer Res. 2022 Feb 23;41(1):75. doi: 10.1186/s13046-022-02284-7.
2022
AOU San Luigi di Orbassano

Salaroglio IC; Belisario DC; Bironzo P; Ananthanarayanan P; Ricci L; Digiovanni S; Fontana S; Napoli F; Sandri A; Facolmatà C; Libener R; Comunanza V; Grosso F; Gazzano E; Leo F; Taulli R; Bussolino F; Righi L; Papotti MG; Novello S; Scagliotti GV; Riganti C; Kopecka J;

Malignant pleural mesothelioma: new guidelines make us stronger for defeating this disease. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2022 Feb;33(2):123-125. doi: 10.1016/j.annonc.2021.11.019. Epub 2021 Dec 6.
2022
AOU San Luigi di Orbassano

Remon J; Hendriks LEL; Bironzo P; Remon J; Hendriks LEL; Bironzo P;

Immune Checkpoint Inhibitors and Opioids in Patients with Solid Tumours: Is Their Association Safe? A Systematic Literature Review. in Healthcare (Basel, Switzerland) / Healthcare (Basel). 2022 Dec 30;11(1):116. doi: 10.3390/healthcare11010116.
2022
AOU San Luigi di Orbassano

Cani M; Bironzo P; Garetto F; Buffoni L; Cotogni P;

Squamous cell histological transformation in a lung adenocarcinoma patient (hyper) progressing upon immunotherapy. in Tumori / Tumori. 2022 Dec;108(6):NP15-NP19. doi: 10.1177/03008916221080487. Epub 2022 Mar 11.
2022
AOU San Luigi di Orbassano

Mariniello A; Righi L; Morrone A; Carnio S; Bironzo P;

Correction to: Micro-RNA-215 and -375 regulate thymidylate synthase protein expression in pleural mesothelioma and mediate epithelial to mesenchymal transition. in Virchows Archiv : an international journal of pathology / Virchows Arch. 2022 Aug;481(2):331. doi: 10.1007/s00428-022-03355-y.
2022
AOU San Luigi di Orbassano

Napoli F; Rapa I; Izzo S; Rigutto A; Libener R; Riganti C; Bironzo P; Taulli R; Papotti M; Volante M; Scagliotti G; Righi L;

Micro-RNA-215 and -375 regulate thymidylate synthase protein expression in pleural mesothelioma and mediate epithelial to mesenchymal transition. in Virchows Archiv : an international journal of pathology / Virchows Arch. 2022 Aug;481(2):233-244. doi: 10.1007/s00428-022-03321-8. Epub 2022 Apr 24.
2022
AOU San Luigi di Orbassano

Napoli F; Rapa I; Izzo S; Rigutto A; Libener R; Riganti C; Bironzo P; Taulli R; Papotti M; Volante M; Scagliotti G; Righi L;

2022
AOU San Luigi di Orbassano

Bironzo P; Melocchi L; Monica V; Trebeschi D; Barbieri F; Maiello E; Migliorino MR; Lombardi A; Tiseo M; Righi L; Graziano P; Rossi G; Novello S;

A systematic review and meta-analysis of trials assessing PD-1/PD-L1 immune checkpoint inhibitors activity in pre-treated advanced stage malignant mesothelioma. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2022 Apr;172:103639. doi: 10.1016/j.critrevonc.2022.103639. Epub 2022 Feb 19
2022
ASL Asti
AOU San Luigi di Orbassano

Passiglia F; Novello S; Buffoni L; Carnio S; Capelletto E; Zichi C; Reale ML; Artusio E; Olmetto E; Bungaro M; Paratore C; Bertaglia V; Audisio M; Rapetti SG; Pignataro D; Curcio H; De Luca E; Bironzo P; Tagliamento M; Scagliotti GV; Di Maio M;

Winds From the ORIENT: New Data to Inform RATIONAL Choice? in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2021 Sep;16(9):1434-1436. doi: 10.1016/j.jtho.2021.07.003.
2021
AOU San Luigi di Orbassano

Bironzo P; Passiglia F; Novello S;

Repositioning PARP inhibitors in the treatment of thoracic malignancies. in Cancer treatment reviews / Cancer Treat Rev. 2021 Sep;99:102256. doi: 10.1016/j.ctrv.2021.102256. Epub 2021 Jul 7.
2021
AOU San Luigi di Orbassano

Passiglia F; Reale ML; Cetoretta V; Parlagreco E; Jacobs F; Listì A; Righi L; Bironzo P; Novello S; Scagliotti GV;

Immune checkpoint inhibitors a new player in the therapeutic game of mesothelioma: New reality with new challenges. in Cancer treatment reviews / Cancer Treat Rev. 2021 Sep;99:102250. doi: 10.1016/j.ctrv.2021.102250. Epub 2021 Jun 16.
2021
AOU San Luigi di Orbassano

Parikh K; Hendriks LEL; Bironzo P; Remon J;

Pathological Characterization of Tumor Immune Microenvironment (TIME) in Malignant Pleural Mesothelioma. in Cancers / Cancers (Basel). 2021 May 24;13(11):2564. doi: 10.3390/cancers13112564.
2021
AOU San Luigi di Orbassano

Napoli F; Listì A; Zambelli V; Witel G; Bironzo P; Papotti M; Volante M; Scagliotti G; Righi L;

2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Novello S; Scagliotti GV; Bussolino F; Di Maio M; Righi L; Passiglia F; Listì A; Caglio A; Sperone T; Tabbò F; Reale ML; Bironzo P;

Evaluation of the Preclinical Efficacy of Lurbinectedin in Malignant Pleural Mesothelioma. in Cancers / Cancers (Basel). 2021 May 12;13(10):2332. doi: 10.3390/cancers13102332.
2021
AOU Alessandria
AOU San Luigi di Orbassano

Aviles P; Libener R; Leo F; Guerrera F; Sandri A; Comunanza V; Gigliotti C; Bussolino F; Di Nicolantonio F; Pittaro A; Papotti MG; Napoli F; Righi L; Morena D; Lingua MF; Picca F; Bironzo P; Anobile DP; Novello S; Taulli R; Scagliotti GV; Riganti C;

Local for advanced, is this a paradox? in Translational lung cancer research / Transl Lung Cancer Res. 2021 Jul;10(7):3324-3328. doi: 10.21037/tlcr-20-771.
2021
AOU San Luigi di Orbassano

Bungaro M; Paratore C; Bironzo P; Novello S;

Immune-checkpoint inhibition in stage III unresectable NSCLC: Challenges and opportunities in the post-PACIFIC era. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2021 Jul;157:85-91. doi: 10.1016/j.lungcan.2021.05.009. Epub 2021 May 11.
2021
AOU San Luigi di Orbassano

Passiglia F; Leone G; Olmetto E; Delcuratolo MD; Tabbò F; Reale ML; Bertaglia V; Consito L; Bironzo P; Capelletto E; Novello S;

Predicting immunotherapy outcomes under therapy in patients with advanced NSCLC using dNLR and its early dynamics. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 Jul;151:211-220. doi: 10.1016/j.ejca.2021.03.011. Epub 2021 May 19.
2021
AOU San Luigi di Orbassano

Mezquita L; Preeshagul I; Auclin E; Saravia D; Hendriks L; Rizvi H; Park W; Nadal E; Martin-Romano P; Ruffinelli JC; Ponce S; Audigier-Valette C; Carnio S; Blanc-Durand F; Bironzo P; Tabbò F; Reale ML; Novello S; Hellmann MD; Sawan P; Girshman J; Plodkowski AJ; Zalcman G; Majem M; Charrier M; Naigeon M; Rossoni C; Mariniello A; Paz-Ares L; et alii...

2021
AOU San Luigi di Orbassano

Scagliotti GV; Volante M; Novello S; Arizio F; Listì A; Righi L; Passiglia F; Bironzo P;

Thymidylate synthase drives the phenotypes of epithelial-to-mesenchymal transition in non-small cell lung cancer. in British journal of cancer / Br J Cancer. 2021 Jan;124(1):281-289. doi: 10.1038/s41416-020-01095-x. Epub 2020 Oct 7.
2021
AOU San Luigi di Orbassano

Asangani IA; Schuhwerk H; Bironzo P; Saatci O; Rapa I; Natesan R; Vazakidou ME; Schwab A; Parma B; Ramesh V; Gollavilli PN; Siddiqui MA; Sahin O; Volante M; Ceppi P;

Italian survey on the clinical management of non-small cell lung cancer patients during the COVID-19 pandemic: A lesson for the second wave. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2021 Jan;157:103189. doi: 10.1016/j.critrevonc.2020.103189. Epub 2020 Nov 27
2021
AOU San Luigi di Orbassano

Sperone P; Capelletto E; Artusio E; Carnio S; Di Stefano RF; Rapetti S; Audisio M; Bungaro M; Tabbò F; Leone G; Mariniello A; Palesandro E; Bironzo P; Reale ML; Bertaglia V; Passiglia F; Novello S;

Major breakthroughs in lung cancer adjuvant treatment: Looking beyond the horizon. in Cancer treatment reviews / Cancer Treat Rev. 2021 Dec;101:102308. doi: 10.1016/j.ctrv.2021.102308. Epub 2021 Oct 18.
2021
AOU San Luigi di Orbassano

Passiglia F; Bertaglia V; Reale ML; Delcuratolo MD; Tabbò F; Olmetto E; Capelletto E; Bironzo P; Novello S;

2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Novello S; Di Maio M; Passiglia F; Capelletto E; Boccuzzi A; Caramello V; Olmetto E; Persano I; De Filippis M; Pisano C; Bironzo P; Mariniello A;

Exploring the role of respiratory microbiome in lung cancer: A systematic review. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2021 Aug;164:103404. doi: 10.1016/j.critrevonc.2021.103404. Epub 2021 Jun 29
2021
ASL Asti
AOU San Luigi di Orbassano

Galetta D; Tiseo M; Menis J; Facchinetti F; Bironzo P; Sartori G; Russano M; Rinaldi S; Prelaj A; Pignataro D; Montrone M; Meacci F; Di Noia V; Bianconi M; Mazzotta M; Perrone F; Belluomini L; Novello S; Pilotto S;

Dealing with NSCLC EGFR mutation testing and treatment: A comprehensive review with an Italian real-world perspective. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2021 Apr;160:103300. doi: 10.1016/j.critrevonc.2021.103300. Epub 2021 Mar 17
2021
AOU San Luigi di Orbassano

Malapelle U; Pilotto S; Passiglia F; Pepe F; Pisapia P; Righi L; Listì A; Bironzo P; Belluomini L; Tabbò F; Reale ML; Russo G; De Luca C; Novello S; Troncone G;

2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Novara

Pinato DJ; Ficorella C; Porzio G; Cannita K; Addeo A; Banna GL; Friedlaender A; Spinelli GP; Russo A; Adamo V; Metro G; Bironzo P; Passiglia F; Ricciardi S; Migliorino MR; Landi L; Minuti G; Tuzi A; Bordi P; Russano M; Cantini L; Santini D; Citarella F; Zoratto F; Filetti M; Mansueto G; Di Marino P; Grassadonia A; Inno A; et alii...

Performing oncological procedures during COVID-19 outbreak: a picture from an Italian cancer center. in Exploration of targeted anti-tumor therapy / Explor Target Antitumor Ther. 2021;2(5):481-489. doi: 10.37349/etat.2021.00058. Epub 2021 Oct 31.
2021
AOU San Luigi di Orbassano

Bungaro M; Bertaglia V; Audisio M; Parlagreco E; Pisano C; Cetoretta V; Persano I; Jacobs F; Baratelli C; Consito L; Reale ML; Tabbò F; Bironzo P; Scagliotti GV; Novello S;

Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ??50. in Cancer immunology, immunotherapy : CII / Cancer Immunol Immunother. 2020 Nov;69(11):2209-2221. doi: 10.1007/s00262-020-02613-9. Epub 2020 May
2020
AOU San Luigi di Orbassano

Cortellini A; Tiseo M; Banna GL; Cappuzzo F; Aerts JGJV; Barbieri F; Giusti R; Bria E; Cortinovis D; Grossi F; Migliorino MR; Galetta D; Passiglia F; Santini D; Berardi R; Morabito A; Genova C; Mazzoni F; Di Noia V; Signorelli D; Tuzi A; Gelibter A; Marchetti P; Macerelli M; Rastelli F; Chiari R; Rocco D; Gori S; De Tursi M; et alii...

New emerging targets in cancer immunotherapy: the role of VISTA. in ESMO open / ESMO Open. 2020 Jun;4(Suppl 3):e000683. doi: 10.1136/esmoopen-2020-000683.
2020
AOU San Luigi di Orbassano

Tagliamento M; Bironzo P; Novello S;

Wnt/IL-1?/IL-8 autocrine circuitries control chemoresistance in mesothelioma initiating cells by inducing ABCB5. in International journal of cancer / Int J Cancer. 2020 Jan 1;146(1):192-207. doi: 10.1002/ijc.32419. Epub 2019 Jun 4.
2020
AOU San Luigi di Orbassano

Milosevic V; Kopecka J; Salaroglio IC; Libener R; Napoli F; Izzo S; Orecchia S; Ananthanarayanan P; Bironzo P; Grosso F; Tabbò F; Comunanza V; Alexa-Stratulat T; Bussolino F; Righi L; Novello S; Scagliotti GV; Riganti C; Milosevic V; Kopecka J; Salaroglio IC; Libener R; Napoli F; Izzo S; Orecchia S; Ananthanarayanan P; Bironzo P; Grosso F; Tabbò F; et alii...

Quality of life analysis in lung cancer: A systematic review of phase III trials published between 2012 and 2018. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2020 Jan;139:47-54. doi: 10.1016/j.lungcan.2019.10.022. Epub 2019 Oct 31.
2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Scagliotti GV; Aglietta M; Perrone F; Novello S; Bironzo P; Sonetto C; Muratori L; La Salvia A; Leone G; Trevisi E; Mariniello A; Pignataro D; Di Stefano RF; Ghisoni E; Zichi C; Lombardi P; Marandino L; De Luca E; Reale ML; Di Maio M;

Resistance to anaplastic lymphoma kinase inhibitors: knowing the enemy is half the battle won. in Translational lung cancer research / Transl Lung Cancer Res. 2020 Dec;9(6):2545-2556. doi: 10.21037/tlcr-20-372.
2020
AOU San Luigi di Orbassano

Tabbò F; Reale ML; Bironzo P; Scagliotti GV;

Future perspectives from lung cancer pre-clinical models: new treatments are coming? in Translational lung cancer research / Transl Lung Cancer Res. 2020 Dec;9(6):2629-2644. doi: 10.21037/tlcr-20-189.
2020
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Righi L; Bironzo P; Tabbò F; Morotti A; Picca F; Morena D; Bersani F; Taulli R;

Is there any place for immune-checkpoint inhibitors in the treatment algorithm of fusion-driven non-small cell lung cancer?-a literature review. in Translational lung cancer research / Transl Lung Cancer Res. 2020 Dec;9(6):2674-2685. doi: 10.21037/tlcr-20-710.
2020
AOU San Luigi di Orbassano

Leone G; Passiglia F; Bironzo P; Bertaglia V; Novello S;

Five-year overall survival of pembrolizumab in advanced non-small cell lung cancer: another step from care to cure? in Annals of translational medicine / Ann Transl Med. 2019 Sep;7(Suppl 6):S212. doi: 10.21037/atm.2019.08.91.
2019
AOU San Luigi di Orbassano

Bironzo P; Passiglia F; Novello S;

Systematic Review of adverse events reporting in clinical trials leading to approval of targeted therapy and immunotherapy. in Future oncology (London, England) / Future Oncol. 2019 Jul;15(21):2543-2553. doi: 10.2217/fon-2018-0772. Epub 2019 Jun 26.
2019
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Locati LD; Di Giannantonio V; Sbrana A; Musettini G; Sonetto C; Bironzo P; Botta L; Bossi P; Di Maio M; Antonuzzo A;

Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma. in Proceedings of the National Academy of Sciences of the United States of America / Proc Natl Acad Sci U S A. 2019 Feb 5;116(6):2226-2231. doi: 10.1073/pnas.1818865116. Epub 2019 Jan 1
2019
AOU San Luigi di Orbassano

Villanova T; Gesmundo I; Audrito V; Vitale N; Silvagno F; Musuraca C; Righi L; Libener R; Riganti C; Bironzo P; Deaglio S; Papotti M; Cai R; Sha W; Ghigo E; Schally AV; Granata R;

First-line immune-chemotherapy combination: the right strategy to fight squamous non-small cell lung cancer? in Translational lung cancer research / Transl Lung Cancer Res. 2019 Aug;8(4):546-549. doi: 10.21037/tlcr.2019.04.05.
2019
AOU San Luigi di Orbassano

Passiglia F; Bironzo P; Scagliotti GV;

Potential Diagnostic and Prognostic Role of Microenvironment in Malignant Pleural Mesothelioma. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2019 Aug;14(8):1458-1471. doi: 10.1016/j.jtho.2019.03.029. Epub 2019 May 9.
2019
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Riganti C; Scagliotti GV; Papotti M; Di Maio M; Novello S; Righi L; Ruffini E; Bussolino F; Ardissone F; Comunanza V; Passone E; Cartia CF; Tabbò F; Ananthanarayanan P; Bironzo P; Gagliasso M; Milosevic V; Costardi L; Maletta F; Salaroglio IC; Kopecka J; Napoli F; Pradotto M;

NIBIT-MESO-1: limitations and clinical perspectives in MPM treatment testing an immune checkpoint blockade combination in a single-arm study. in Journal of thoracic disease / J Thorac Dis. 2018 Nov;10(Suppl 33):S3878-S3881. doi: 10.21037/jtd.2018.09.135.
2018
AOU San Luigi di Orbassano

Bironzo P; Taulli R;

A review of guidelines for lung cancer. in Journal of thoracic disease / J Thorac Dis. 2018 May;10(Suppl 13):S1556-S1563. doi: 10.21037/jtd.2018.03.54.
2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Di Maio M; Bironzo P;

Thymidine phosphorylase: the unforeseen driver in colorectal cancer treatment? in Future oncology (London, England) / Future Oncol. 2018 May;14(12):1223-1231. doi: 10.2217/fon-2017-0627. Epub 2018 Apr 27.
2018
AOU San Luigi di Orbassano

Tampellini M; Bironzo P; Di Maio M; Scagliotti GV;

Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identification. in Nature biotechnology / Nat Biotechnol. 2018 Dec 17. doi: 10.1038/nbt.4313.
2018
AOU San Luigi di Orbassano

Bulik-Sullivan B; Busby J; Palmer CD; Davis MJ; Murphy T; Clark A; Busby M; Duke F; Yang A; Young L; Ojo NC; Caldwell K; Abhyankar J; Boucher T; Hart MG; Makarov V; Montpreville VT; Mercier O; Chan TA; Scagliotti G; Bironzo P; Novello S; Karachaliou N; Rosell R; Anderson I; Gabrail N; Hrom J; Limvarapuss C; Choquette K; et alii...

2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Aglietta M; Novello S; Bironzo P; Marcato M; Muratori L; Leone G; Trevisi E; Reale ML; Mariniello A; Lombardi P; Ghisoni E; Di Stefano RF; Zichi C; Pignataro D; De Luca E; Sonetto C; La Salvia A; Marandino L; Scagliotti GV; Perrone F; Di Maio M;

Efficacy of neurokinin-1 receptor antagonists in the prevention of chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based chemotherapy: A systematic review and meta-analysis. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2018 Apr;124:21-28. doi: 10.1016/j.critrevonc.2018.02.001. Epub 2018 Feb 7.
2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Sperti E; Marcato M; Bria E; Vignani F; Bironzo P; Baratelli C; Di Maio M; Roila F;

Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment. in Oncoimmunology / Oncoimmunology. 2017 Nov 27;7(3):e1398874. doi: 10.1080/2162402X.2017.1398874. eCollection 2018.
2018
AOU San Luigi di Orbassano

Riganti C; Lingua MF; Salaroglio IC; Falcomatà C; Righi L; Morena D; Picca F; Oddo D; Kopecka J; Pradotto M; Libener R; Orecchia S; Bironzo P; Comunanza V; Bussolino F; Novello S; Scagliotti GV; Di Nicolantonio F; Taulli R; Riganti C; Lingua MF; Salaroglio IC; Falcomatà C; Righi L; Morena D; Picca F; Oddo D; Kopecka J; Pradotto M; et alii...

Pathogenesis, clinical manifestations and management of immune checkpoint inhibitors toxicity. in Tumori / Tumori. 2017 Sep 18;103(5):405-421. doi: 10.5301/tj.5000625. Epub 2017 May 10.
2017
AOU San Luigi di Orbassano

Inno A; Metro G; Bironzo P; Grimaldi AM; Grego E; Di Nunno V; Picasso V; Massari F; Gori S;

Raising the bar for enthusiasm when looking at results of randomized phase II trials-the case of sunitinib in small-cell lung cancer. in Translational lung cancer research / Transl Lung Cancer Res. 2016 Feb;5(1):89-91. doi: 10.3978/j.issn.2218-6751.2015.07.18.
2016
AOU San Luigi di Orbassano

Di Maio M; Bironzo P; Scagliotti GV;

Understanding and overcoming the mechanisms of primary and acquired resistance to abiraterone and enzalutamide in castration resistant prostate cancer. in Cancer treatment reviews / Cancer Treat Rev. 2015 Dec;41(10):884-92. doi: 10.1016/j.ctrv.2015.08.002. Epub 2015 Aug 31.
2015
AOU San Luigi di Orbassano

Buttigliero C; Tucci M; Bertaglia V; Vignani F; Bironzo P; Di Maio M; Scagliotti GV;

Moving from histological subtyping to molecular characterization: new treatment opportunities in advanced non-small-cell lung cancer. in Expert review of anticancer therapy / Expert Rev Anticancer Ther. 2014 Dec;14(12):1495-513. doi: 10.1586/14737140.2014.949245. Epub 2014 S
2014
AOU San Luigi di Orbassano

Carnio S; Novello S; Bironzo P; Scagliotti GV;

Strategies for managing ACTH dependent mineralocorticoid excess induced by abiraterone. in Cancer treatment reviews / Cancer Treat Rev. 2013 Dec;39(8):966-73. doi: 10.1016/j.ctrv.2013.03.003. Epub 2013 Apr 10.
2013
AOU San Luigi di Orbassano

Pia A; Vignani F; Attard G; Tucci M; Bironzo P; Scagliotti G; Arlt W; Terzolo M; Berruti A;